malignant solid tumor
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: patients with malignant solid tumor and undergo high dose ifosfamide therapy under 40 years old
Exclusion criteria
Exclusion criteria: patient with brain metastasis patients who have neurological and/or psychological symptom poor performance status
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| neurological and pshychological symptoms | — |
Secondary
| Measure | Time frame |
|---|---|
| electroencephalogram MRI FGD-PET | — |
Countries
Japan
Contacts
Saitama Medical University International Medical Center Department of Pediatric Oncology